Skip to Main Content

Paper Details

Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targets.
Clin Genitourin Cancer
1
2022
Author NameAffiliation
Philippe L BedardPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 1

Datasets

Release 1.2